Neoadjuvant immunotherapy: new horizon for lymph node preservation
MedComm · 2024-05 · 5 (5)
DOI: 10.1002/mco2.577 ↗At a glance
Journal article in MedComm, published online on 2024-05-13. Written by Nian-Nian Zhong and 2 co-authors. Institution: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Cited 14 times so far (Crossref); 5 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Hubei Province.
Abstract (original language)
The study by Rahim et al., focusing on preoperative immunotherapy, highlights the pivotal role of CD8+ T cells within lymph nodes in response to neoadjuvant immunotherapy, suggesting that preserving lymph node integrity could bolster the treatment's efficacy by activating antitumor T cells. This underlines the importance of lymph node preservation and supports the use of immunotherapy as a neoadjuvant approach in cancer treatment.
Subjects
Author keywords
Authors and institutions
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology School & Hospital of Stomatology, Wuhan Univers…
- Department of Oral & Maxillofacial-Head Neck Oncology School & Hospital of Stomatology, Wuhan University Wuhan China.
ORCID profiles: Lin-Lin Bu
Funding
- Natural Science Foundation of Hubei Province
Cite
APA
Zhong, N. N., Liu, B., & Bu, L. L. (2024). Neoadjuvant immunotherapy: new horizon for lymph node preservation. MedComm, 5(5). https://doi.org/10.1002/mco2.577
Vancouver
Zhong NN, Liu B, Bu LL. Neoadjuvant immunotherapy: new horizon for lymph node preservation. MedComm. 2024;5(5). doi:10.1002/mco2.577
BibTeX
@article{Zhong2024,
author = {Zhong, Nian-Nian and Liu, Bing and Bu, Lin-Lin},
title = {Neoadjuvant immunotherapy: new horizon for lymph node preservation},
journal = {MedComm},
year = {2024},
volume = {5},
number = {5},
doi = {10.1002/mco2.577}
}
EUVIMED